scispace - formally typeset
M

Mike Sharland

Researcher at St George's, University of London

Publications -  427
Citations -  21638

Mike Sharland is an academic researcher from St George's, University of London. The author has contributed to research in topics: Population & Neonatal sepsis. The author has an hindex of 59, co-authored 401 publications receiving 14589 citations. Previous affiliations of Mike Sharland include St. George's University & University of London.

Papers
More filters
Journal ArticleDOI

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Evelina Tacconelli, +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J L Murray, +174 more
- 01 Jan 2022 - 
TL;DR: This study provides the first comprehensive assessment of the global burden of AMR, as well as an evaluation of the availability of data, and estimates aggregated to the global and regional level.
Journal ArticleDOI

A living WHO guideline on drugs for covid-19

Bram Rochwerg, +59 more
- 04 Sep 2020 - 
TL;DR: A standing international panel of content experts, patients, clinicians, and methodologists, free from relevant conflicts of interest, produce recommendations for clinical practice, containing a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19, and a weak or conditional recommendation against systemic cortiosteroids for non-severe patients.
Journal ArticleDOI

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

David W. Kimberlin, +43 more
TL;DR: Treating symptomatic congenital CMV disease with valganciclovir for 6 months, as compared with 6 weeks, did not improve hearing in the short term but appeared to improve hearing and developmental outcomes modestly in the longer term.
Journal ArticleDOI

Neonatal sepsis: an international perspective

TL;DR: To reduce global neonatal mortality, strategies of proven efficacy, such as hand washing, barrier nursing, restriction of antibiotic use, and rationalisation of admission to neonatal units, need to be implemented.